XML 18 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 8 Months Ended 12 Months Ended
Dec. 31, 2023
Dec. 31, 2024
Apr. 30, 2023
Cash Flows from Operating Activities:      
Net (loss) income $ (1,251,259) $ (26,022,349) $ (5,452,383)
Adjustments to reconcile net (loss) income to net cash used in operating activities:      
Depreciation and amortization 289,067 466,691 157,802
Stock based compensation - employees 207,453
Stock based compensation - services 108,730
Legal & professional expenses 3,045,290  
Amortization of loan discounts and origination fees 181,875
Write-off of capitalized software costs 145,746
Impairment of goodwill and intangible assets 18,280,947
Commitment fee expenses 500,000
Loss on sale of properties (85,077) 301 (22,817)
Gain on previously held equity (20,663)
Gain on sale of myAlphie (5,502,774)
Changes in operating assets and liabilities:      
Accounts receivable 37,490 (16,437) 65,696
Receivable from related parties 20,874 (12,873) (20,874)
Payable to related parties (56,241)
Prepaid expenses (226,889) 62,637 96,038
Other current assets (419,849) (19,773) (81,689)
Accounts payable 48,928 58,756 235,433
Accrued expenses 621,815 (185,118) 60,741
Deferred liabilities 593,750 278,080
Total adjustments (1,577,375) 19,980,111 490,330
Net cash used in operating activities (2,828,634) (6,042,238) (4,962,053)
Cash Flows from Investing Activities:      
Proceeds from sale of properties 731,343 293,307 1,539,997
Additions to property, plant & equipment (40,840) (12,533) 19,721
Cash paid to acquire business (50,000) (1,268,630) (25,000)
Cash paid for equity method investment (50,000)
Cash used for additions to capitalized software development and intangibles (134,400) (516,544) (452,451)
Net cash (used in) provided by investing activities 506,103 (1,554,400) 1,082,267
Cash Flows from Financing Activities:      
Proceeds from issuance of debt 190,095 6,155,539 247,000
Payments of debt (1,164,241) (1,071,709)
Deferred financing costs (727,500)
Proceeds from issuance of common stock 7,331,938 4,282,274
Offering costs paid on issuance of common stock (416,312)
Net cash provided by financing activities 7,522,033 4,263,798 3,041,253
Net (decrease) increase in cash 5,199,502 (3,332,840) (838,533)
Cash - Beginning of Period 1,256,868 6,456,370 2,095,401
Cash - End of Period 6,456,370 3,123,530 1,256,868
Supplemental disclosure of cash flow information      
Interest expense $ (70,119) $ (58,897) $ (169,776)